Latest Shareholder Value News

Beamtree Holdings appoints Marek Stepniak as CEO, signaling a strategic push in international markets with a strong leadership hand familiar with the company’s growth trajectory.

Nufarm Limited’s 2025 AGM revealed a resilient FY24 performance despite industry headwinds, with strong growth in omega-3 canola and strategic cost-saving initiatives setting the stage for future expansion.

Micro-X Limited has requested an immediate voluntary suspension of its shares on the ASX, pending a forthcoming equity raising announcement expected by February 10.

Nufarm’s 2025 AGM revealed a resilient FY24 performance despite industry headwinds, with strategic investments in omega-3 canola, biofuels, and cost-saving initiatives setting the stage for growth in FY25.

Trigg Minerals has expanded its New South Wales antimony holdings by acquiring the historic Bukkulla Mine and extending its footprint into the Nundle Goldfield, confirming high-grade antimony potential and setting the stage for systematic exploration.

Athena Resources has appointed Peter Jones as Managing Director and CEO, aiming to leverage his extensive Mid-West iron ore experience to advance the high-grade Byro Magnetite Project.

Mako Gold Limited’s securities have been suspended from ASX trading following Aurum Resources’ dispatch of compulsory acquisition notices, signaling a pivotal ownership transition.

Maas Group Holdings has announced a fresh on-market share buyback of up to 10% of its issued capital, signaling strong confidence in its financial health and future prospects.

Medlab Clinical reports a near-empty cash balance and zero receipts in Q2 2025, while actively pursuing a business acquisition ahead of its ASX removal date.

Sigma Healthcare has received Federal Court approval for its acquisition of Chemist Warehouse, marking a pivotal step in its strategic expansion. The scheme is set to become legally effective on February 4, 2025, with implementation expected by February 12.

Viridis Mining and Minerals Limited has requested an immediate voluntary suspension of its shares pending a capital raising announcement, signaling a pivotal moment for the company.

ARGO Investments Limited has announced a fully franked ordinary dividend of AUD 0.17 per share for the six months ending December 31, 2024, with payment scheduled for March 14, 2025. Shareholders can opt into a Dividend Reinvestment Plan or Bonus Security Plan, both without discounts.